Results 151 to 160 of about 5,687 (195)
Final results and overall survival data from a phase II study of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma, including those with poor prognostic factors [PDF]
Calvo, Roser, Davies, Andrew J., Doorduijn, Jeanette K., Długosz-Danecka, Monika, Eek, Richard, Goy, Andre, Jacobsen, Eric, Jain, Preetesh, Kater, Arnon P., Le Gouill, Steven, Panizo, Carlos, Robak, Tadeusz, Rule, Simon, Shah, Bijal D., Smith, Stephen D., Tao, Lin, Wang, Michael, Zinzani, Pier Luigi +17 morecore +1 more sourceAcalabrutinib in High-Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real-Life Experience [PDF]
Autore, Francesco, Corbingi, Andrea, Coscia, Marta, Del Principe, Maria Ilaria, Deodato, Marina, Farina, Giuliana, Fresa, Alberto, Frustaci, Anna Maria, Galitzia, Andrea, Gentile, Massimo, Ghia, Paolo, Giannarelli, Diana, Innao, Vanessa, Innocenti, Idanna, Laureana, Roberta, Laurenti, Luca, Martini, Francesca, Morelli, Francesca, Mosca, Antonio, Murru, Roberta, Olivieri, Jacopo, Pasquale, Raffaella, Perutelli, Francesca, Romeo, Azzurra, Sanna, Alessandro, Scarfò, Lydia, Sportoletti, Paolo, Stirparo, Luca, Tedeschi, Alessandra, Tomasso, Annamaria, Visentin, Andrea, Vitale, Candida +31 morecore +2 more sourcesAddressing cardiovascular toxicities of Bruton tyrosine kinase inhibitors in chronic lymphocytic leukaemia: practical recommendations for haematologists in central and eastern Europe. [PDF]
CardiooncologyAurer I, Bulj N, Demirevska L, Dragnić S, Dreisinger M, Goranova-Marinova V, Jakšić O, Lipar L, Rener K, Spassov B, Urošević I, Vukovic V, Žarić E, Zdravković M. +13 moreeuropepmc +1 more sourceAcalabrutinib treatment for older (aged ≥80 years) and/or frail patients with CLL: primary end point analysis of the CLL-Frail trial.
BloodSimon F, Ligtvoet R, Bohn JP, Nösslinger T, von Tresckow J, Liersch R, Gaska T, Jentsch-Ullrich K, Gärtner M, Wolff T, Schwaner I, Wolf D, Schneider C, Vehling-Kaiser U, Ritgen M, Spoer C, Eckart M, Decker T, Chakupurakal G, Schöttker B, Kisro J, Kreuzer KA, Tausch E, Stilgenbauer S, Robrecht S, Stumpf J, Fink AM, Fürstenau M, Fischer K, Goede V, Hallek M, Eichhorst B. +31 moreeuropepmc +1 more sourceSome of the next articles are maybe not open access.Related searches:
